Influenza A (H1N1) 2009 Monovalent Vaccine

Influenza A (H1N1) 2009 Monovalent Vaccine is an inactivated influenza virus vaccine indicated for immunization of persons 4 years of age and older against influenza disease caused by pandemic (H1N1) 2009 virus.

The product’s dosage form is injection, suspension and is administered via intramuscular form.

Manufacturer’s Name: Anzalp Pharmasolutions Pvt. Ltd.

Dosage Form:  Suspension for Injection – A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble.

Product Type: Vaccine 

Influenza A (H1N1) 2009 Monovalent Vaccine ACTIVE INGREDIENT

• A/California/7/2009 (H1N1)v-like virus 15 Ug/0.5ml 

ADMINISTRATION ROUTE

• Intramuscular – Administration within a muscle.

HOW SUPPLIED

• Supplied as package of Single-dose vial, 0.5 mL (not made with natural rubber latex).
• Multi-dose vial, 5 mL  (not made with natural rubber latex). Supplied as package of 1. A maximum of ten doses can be withdrawn from the multi-dose vial.

STORAGE AND HANDLING

Store all Influenza A (H1N1) 2009 Monovalent Vaccinepresentations refrigerated at 2° to 8°C (35° to 46°F). DO NOT FREEZE. Discard if vaccine has been frozen. Do not use after the expiration date shown on the label.